Clinical Trials Logo

Postoperative Complications clinical trials

View clinical trials related to Postoperative Complications.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 11

NCT ID: NCT01876836 Not yet recruiting - Clinical trials for Prostate Hyperplasia

Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications

C-LMA
Start date: July 2013
Phase: Phase 4
Study type: Interventional

1. i-gel 2. C-LMA Compare the effect on gastroeosephageal reflux Postoperative complicatios.

NCT ID: NCT01722981 Not yet recruiting - Clinical trials for Other Tracheostomy Complication

Percutaneous Tracheostomy - Systematic Comparison Among Three Methods: Prospective Study

Start date: January 2013
Phase: N/A
Study type: Interventional

Percutaneous tracheostomy is routinely performed in most intensive care units in the world.Several studies have shown that the procedure is safe and economically efficient in comparison to open surgical operation in the operating room. In our institution as in a number of institutions in the country, it is acceptable to perform the operation by placing the tube on a high position near the vocal cords by direct laryngoscopy and then puncturing the trachea with a needle, by location of the anatomy by palpation of the neck. Using technological aids, such as direct sonography and bronchoscopy in real time may significantly reduce the rate of complications as a result of performing percutaneous tracheostomy. So far, no systematic comparison has been made among the three methods.

NCT ID: NCT00373919 Not yet recruiting - Clinical trials for Postoperative Complications

The Effect of Erythromycin on Occurrence of Leaks From Cervical Esophageal-Gastric Anastomosis After Trans-Hiatal Esophagectomy

Start date: n/a
Phase: N/A
Study type: Interventional

Cervical anastomotic leak is one of the most common complications after trans-hiatal esophagectomy. Hypothesis: An early post operative administration of a pro-kinetic dosage of erythromycin will reduce leak occurrence. Design: This is a prospective, randomized, double blind, placebo controlled study. Number of patients: 30. Inclusion Criteria: - Patients after trans-hiatal esophagectomy Exclusion Criteria: - Allergy to erythromycin - Use of phenothiazine - QT prolongation - Liver function test (LFT) abnormalities - Myasthenia gravis - Cardiomyopathy